Lilly's Lasmiditan NDA Review Could Hinge On US FDA's Migraine Guidance

 
• By Bridget Silverman
  
Migraine word written on wood block
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet